The FDA's final Medical Device Data System (MDDS) rule and its implications for currently regulated and unregulated vendors and providers


Instructor: Tim Gee
Product ID: 700959

  • Duration: 65 Min
The presentation will consider potential impacts of the rule on regulated and unregulated vendors, and providers. This session will survey the market affected by the proposed rule, and define the common components and capabilities of these systems.
Last Recorded Date: Jul-2011


1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section
(For multiple locations contact Customer Care)

Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days
(For multiple locations contact Customer Care)



Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

The FDA signaled a shift from regulatory discretion to enforcement discretion regarding Medical Device Data Systems (MDDS) with the publishing of the final rule on February 14, 2011. Ostensibly, the FDA reclassified these systems from Class III to Class I. But the most remarkable consequence from the final rule is naming of specific entities that may be subject to potential FDA enforcement actions.

The rapid adoption of Electronic Medical Records, advent of Meaningful Use and subsequent desire to automatically acquire medical device data for inclusion in electronic records has resulted in the development and adoption of Medical Device Data Systems. FDA has observed the evolution of this market for some years, and the agency's mandate to ensure patient safety has motivated it to publish this final rule.

This webinar will compare and contrast the proposed and final rule, and discuss what systems and products meet the definition of a MDDS. The named entities that may be subject to enforcement will be discussed, including the FDA's rationale for enforcement authority. Effective compliance dates and required actions will be presented.

Recommended actions in response to the final rule will be presented for each of the applicable groups: regulated manufacturers, unregulated manufacturers and health care providers.

Areas Covered in the Seminar:

  • How the final version of the rule differs from the proposed rule?
  • What systems and products meet the definition of a Medical Device Data System?
  • How the proposed MDDS rule applies to a sample of existing products?
  • Potential targets of FDA enforcement called out in the final MDDS rule.
  • Effective dates for compliance.
  • Potential impact of the final rule on regulated vendors, unregulated vendors, and providers.
  • Potential costs and operational impacts of the proposed rule.

Who Will Benefit:

Manufacturers and providers facing regulatory uncertainty will benefit from a better understanding of the final rule, allowing them to more effectively plan their response and achieve compliance within the rule's effective dates.

  • Medical device manufacturers, health care IT vendors, value added resellers, and dealers
  • Health care provider organizations using MDDS
  • Product managers
  • Risk managers
  • Biomedical/clinical engineers
  • Regulatory affairs personnel

Instructor Profile:

Tim Gee, is the founder and Principal of Medical Connectivity Consulting, and specializes on the convergence of medical devices and information systems. Tim provides consulting services to both vendors and providers. He speaks frequently at industry conferences and corporate events. Tim is on the advisory boards of a number of industry publications, and publishes the Medical Connectivity blog.

Follow us :



Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).




6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube


Copyright © 2023 MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method